Mark Seaton

762 total citations
17 papers, 634 citations indexed

About

Mark Seaton is a scholar working on Cancer Research, Molecular Biology and Pharmacology. According to data from OpenAlex, Mark Seaton has authored 17 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 6 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Mark Seaton's work include Carcinogens and Genotoxicity Assessment (8 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). Mark Seaton is often cited by papers focused on Carcinogens and Genotoxicity Assessment (8 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). Mark Seaton collaborates with scholars based in United States and Canada. Mark Seaton's co-authors include Michele A. Medinsky, James A. Bond, Paul M. Schlosser, Mark H. Follansbee, Bahman Asgharian, Georgia M. Farris, Frank J. Gonzalez, J. Christopher Corton, Susanna S.T. Lee and Elliot S. Vesell and has published in prestigious journals such as Biochemical Journal, Environmental Health Perspectives and Pharmacology & Therapeutics.

In The Last Decade

Mark Seaton

17 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Seaton United States 13 288 274 159 149 59 17 634
James G. Farrelly United States 17 115 0.4× 295 1.1× 115 0.7× 76 0.5× 55 0.9× 41 699
T Fox United States 12 252 0.9× 204 0.7× 62 0.4× 126 0.8× 126 2.1× 29 509
Kathrin Sundberg Sweden 9 153 0.5× 601 2.2× 154 1.0× 79 0.5× 96 1.6× 14 830
Georg F. Kahl Germany 16 153 0.5× 269 1.0× 211 1.3× 80 0.5× 373 6.3× 34 820
Miriam C. Poirier United States 10 370 1.3× 352 1.3× 29 0.2× 166 1.1× 93 1.6× 11 687
Nancy F. Fullerton United States 13 274 1.0× 254 0.9× 40 0.3× 85 0.6× 55 0.9× 21 437
Hans Helleberg Denmark 8 163 0.6× 292 1.1× 51 0.3× 168 1.1× 53 0.9× 18 783
Zeen Tong United States 15 84 0.3× 397 1.4× 207 1.3× 171 1.1× 139 2.4× 35 846
Yoshitaka Tomigahara Japan 14 79 0.3× 627 2.3× 118 0.7× 78 0.5× 69 1.2× 47 1.0k
Masato Kitajima Japan 15 62 0.2× 261 1.0× 122 0.8× 77 0.5× 113 1.9× 20 607

Countries citing papers authored by Mark Seaton

Since Specialization
Citations

This map shows the geographic impact of Mark Seaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Seaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Seaton more than expected).

Fields of papers citing papers by Mark Seaton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Seaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Seaton. The network helps show where Mark Seaton may publish in the future.

Co-authorship network of co-authors of Mark Seaton

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Seaton. A scholar is included among the top collaborators of Mark Seaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Seaton. Mark Seaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Seaton, Mark. (2022). Lessons in automation of meat processing. Animal Frontiers. 12(2). 25–31. 10 indexed citations
2.
Chan‐Tack, Kirk M., Patrick R. Harrington, Suyoung Choi, et al.. (2021). Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation. Antiviral Research. 195. 105182–105182. 55 indexed citations
3.
Varaprath, Sudarsanan, Mark Seaton, Debra A. McNett, Lin Cao, & Kathleen P. Plotzke. (2000). Quantitative Determination of Octamethylcyclotetrasiloxane (D4) in Extracts of Biological Matrices by Gas Chromatography-Mass Spectrometry. International Journal of Environmental & Analytical Chemistry. 77(3). 203–219. 29 indexed citations
4.
Lee, Susanna S.T., Mark Seaton, Bahman Asgharian, et al.. (1996). Reduction of Benzene Metabolism and Toxicity in Mice That Lack CYP2E1 Expression. Toxicology and Applied Pharmacology. 141(1). 205–213. 42 indexed citations
5.
Medinsky, Michele A., Elaina M. Kenyon, Mark Seaton, & Paul M. Schlosser. (1996). Mechanistic considerations in benzene physiological model development.. Environmental Health Perspectives. 104(suppl 6). 1399–1404. 30 indexed citations
6.
Bond, James A., Matthew W. Himmelstein, Mark Seaton, Peter J. Boogaard, & Michele A. Medinsky. (1996). Metabolism of butadiene by mice, rats, and humans: a comparison of physiologically based toxicokinetic model predictions and experimental data. Toxicology. 113(1-3). 48–54. 15 indexed citations
7.
Seaton, Mark, Charles G. Plopper, & James A. Bond. (1996). 1,3-Butadiene metabolism by lung airways isolated from mice and rats. Toxicology. 113(1-3). 314–317. 9 indexed citations
8.
Medinsky, Michele A., Elaina M. Kenyon, Mark Seaton, & Paul M. Schlosser. (1996). Mechanistic Considerations in Benzene Physiological Model Development. Environmental Health Perspectives. 104. 1399–1399. 9 indexed citations
9.
Valentine, John L., Susanna S.T. Lee, Mark Seaton, et al.. (1996). Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicology and Applied Pharmacology. 141(1). 205–213. 152 indexed citations
10.
Seaton, Mark, Mark H. Follansbee, & James A. Bond. (1995). Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis. 16(10). 2287–2293. 88 indexed citations
11.
Seaton, Mark, Paul M. Schlosser, & Michele A. Medinsky. (1995). In vitro conjugation of benzene metabolites by human liver: potential influence of interindividual variability on benzene toxicity. Carcinogenesis. 16(7). 1519–1527. 34 indexed citations
12.
Seaton, Mark, Paul M. Schlosser, James A. Bond, & Michele A. Medinsky. (1994). Benzene metabolism by human liver microsomes in relation to cytochrome P450 2E1 activity. Carcinogenesis. 15(9). 1799–1806. 86 indexed citations
13.
Seaton, Mark & Elliot S. Vesell. (1993). Variables affecting nicotine metabolism. Pharmacology & Therapeutics. 60(3). 461–500. 22 indexed citations
14.
Seaton, Mark, Gabriel A. Kyerematen, & E.S. Vesell. (1993). Rates of excretion of cotinine, nicotine glucuronide, and 3-hydroxycotinine glucuronide in rat bile.. Drug Metabolism and Disposition. 21(5). 927–932. 13 indexed citations
15.
Seaton, Mark, Elliot S. Vesell, Haoming Luo, & E. M. Hawes. (1993). Identification of radiolabeled metabolites of nicotine in rat bile. Journal of Chromatography B Biomedical Sciences and Applications. 621(1). 49–53. 16 indexed citations
16.
Seaton, Mark, et al.. (1991). Nicotine metabolism in stumptailed macaques, Macaca arctoides.. Drug Metabolism and Disposition. 19(5). 946–954. 20 indexed citations
17.
Wallin, Reidar, Mark Seaton, & Louis F. Martin. (1988). No evidence for vitamin K-dependent carboxylation of canine surfactant apoproteins, 28-36 kDa. Biochemical Journal. 252(3). 851–856. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026